ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 26040 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 26040; 2) Community: the network communities that were significantly associated with the response to NSC 26040; 3) Molecule: the relationships between components within communities and NSC 26040; 4) MDR: the compounds that were significantly associated with the NSC 26040.

NSC Compound Enrichment Correlation
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.00628187335688605 0.23370623
NSC 673187 - 0.00628187335688605 0.28824123
NSC 684481 7H-Pyrido[3,2-d][1]benzazepine-6-thione, 2-(3-chloro- phenyl)-5,6-dihydro-4-phenyl- 0.00628187335688605 -0.35821921
NSC 699667 Null 0.00628187335688605 0.18370689
NSC 701314 1H,3H-Thiazolo[3,4-a]benzimidazole, 1-(2,6-dichlorophenyl)-6-methoxy- 0.00628187335688605 0.29442786
NSC 703109 Null 0.00628187335688605 0.20004539
NSC 703544 Null 0.00628187335688605 0.25844016
NSC 714379 Null 0.00628187335688605 0.059626776
NSC 727087 16-[4-(2-diethylaminoethoxy)3-methoxy benzylidene]-17-oxo-5-androsten-3a-yl acetate 0.00628187335688605 0.31223918
NSC 733504 Everolimus 0.00628187335688605 -0.4551401
Total:64  Current:10    [First] [Prev] [Next] [Last]